Century Therapeutics (IPSC) Prepaid Assets (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly Prepaid Assets of $4.2 million for Q1 2026, down 6.08% year-over-year from $4.5 million in Q1 2025, and up 15.9% quarter-over-quarter from $3.7 million in Q4 2025.
Century Therapeutics (IPSC) Prepaid Assets (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Prepaid Assets for 7 consecutive years, with $4.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 6.08% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $4.2 million (down 6.08% YoY), while the FY2025 annual figure was $3.7 million, up 975.0% from the prior year.
- Prepaid Assets grew to $4.2 million in Q1 2026 per IPSC's latest filing, from $3.7 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $7.9 million in Q3 2024 and bottomed at $34000.0 in Q4 2023.
- Historically, Prepaid Assets has averaged $3.4 million across 5 years, with a median of $3.7 million in 2022.
- Annual changes were most pronounced in 2023 — Prepaid Assets sank 97.66% — and 2025, when it soared 975.0%.
- Century Therapeutics' Prepaid Assets stood at $1.5 million in 2022, then tumbled by 97.66% to $34000.0 in 2023, then surged by 900.0% to $340000.0 in 2024, then jumped by 975.0% to $3.7 million in 2025, then rose by 15.9% to $4.2 million in 2026.
- Business Quant data shows IPSC's Prepaid Assets at $4.2 million in Q1 2026, $3.7 million in Q4 2025, and $5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.06 Mn |
| Mar 31, 2026 | 4.24 Mn |
| Dec 31, 2025 | 3.66 Mn |
| Sep 30, 2025 | 4.96 Mn |
| Jun 30, 2025 | 4.33 Mn |
| Mar 31, 2025 | 4.51 Mn |
| Dec 31, 2024 | 340,000.00 |
| Sep 30, 2024 | 7.90 Mn |
| Jun 30, 2024 | 7.08 Mn |
| Mar 31, 2024 | 7.80 Mn |
| Dec 31, 2023 | 34,000.00 |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 1.87 Mn |
| Mar 31, 2023 | 4.47 Mn |
| Dec 31, 2022 | 1.45 Mn |
| Sep 30, 2022 | 354,000.00 |
| Jun 30, 2022 | 373,000.00 |
| Mar 31, 2022 | 3.74 Mn |
| Dec 31, 2021 | 4.77 Mn |
| Sep 30, 2021 | 2.21 Mn |